ClearPoint Neuro (CLPT) Profit After Tax Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.35% |
| Dec 31, 2025 | -37.54% |
| Sep 30, 2025 | -31.75% |
| Jun 30, 2025 | -28.58% |
| Mar 31, 2025 | -24.01% |
| Dec 31, 2024 | -26.76% |
| Sep 30, 2024 | -34.67% |
| Jun 30, 2024 | -23.24% |
| Mar 31, 2024 | -27.70% |
| Dec 31, 2023 | -30.55% |
| Sep 30, 2023 | -27.49% |
| Jun 30, 2023 | -30.31% |
| Mar 31, 2023 | -27.87% |
| Sep 30, 2021 | -9.20% |
| Jun 30, 2021 | -16.00% |
| Mar 31, 2021 | -4.43% |
| Sep 30, 2020 | -43.32% |
| Jun 30, 2020 | 11.50% |
| Mar 31, 2020 | 12.23% |
| Dec 31, 2019 | 2.98% |
| Sep 30, 2019 | 20.99% |
| Jun 30, 2019 | 0.54% |
| Mar 31, 2019 | -19.77% |
| Dec 31, 2018 | 6.62% |
| Sep 30, 2018 | 14.87% |
| Jun 30, 2018 | -6.78% |
| Mar 31, 2018 | -14.78% |
| Sep 30, 2016 | -3.72% |
| Jun 30, 2016 | 2.95% |
| Mar 31, 2016 | 1.91% |